Purchase Order 36C26326P0331
- Not listed
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from the Department of Veterans Affairs' Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on February 6, 2026, with a completion date of February 9, 2026, reflects no set-aside designation and represents a typical procurement structure...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, has been awarded a firm fixed-price purchase order valued at $34,000 by Veterans Integrated Service Network (VISN) 23 for transcatheter aortic valve replacement (TAVR) medical devices. The contract was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and will be performed in Minneapolis, Minnesota. This award represents a direct...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, was awarded a firm fixed-price purchase order valued at $34,000 by the U.S. Department of Veterans Affairs through Veterans Integrated Service Network 23 on September 23, 2025. The contract, which is not set-aside designated, covers transcatheter aortic valve replacement (TAVR) medical devices and is scheduled for completion by September 24, 2025. The award supports the...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis VA) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of January 20, 2026. This contract, awarded on January 16, 2026, carries no set-aside designation and represents Edwards Lifesciences' specialized supply of advanced cardiovascular medical devices to the Department of Veterans Affairs. The award is structured as a...
- Edwards Lifesciences LLC was awarded a $34K firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of March 3, 2026. This award carries no set-aside designation and represents a direct procurement of specialized cardiovascular medical devices essential to the Department of Veterans Affairs' cardiac care mission. The contract reflects Edwards Lifesciences' established...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation specializing in advanced cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, MN) on March 13, 2026, with an ultimate completion date of March 16, 2026. The contract, which carries no set-aside designation, is for transcatheter aortic valve replacement (TAVR) systems and related cardiac technologies to support the Department of...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and recognized leader in cardiovascular medical devices, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 for TAVR (transcatheter aortic valve replacement) products. The contract, which was not set aside for any business category, is scheduled for completion by November 17, 2025, with performance occurring in Minneapolis, Minnesota. As the sole manufacturer of the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a leader in cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on December 12, 2025, with an ultimate completion date of December 15, 2025. The contract, designated as a TAVR (Transcatheter Aortic Valve Replacement) procurement, will be performed in Minneapolis, Minnesota. This award represents no set-aside designation and reflects the...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a global leader in cardiovascular medical devices, was awarded a firm fixed-price purchase order on December 8, 2025, by Veterans Integrated Service Network (VISN) 23 for TAVR (transcatheter aortic valve replacement) equipment and related products. The contract, with a ceiling value of $34,000, has an ultimate completion date of December 10, 2025, and will be performed in Minneapolis, Minnesota. No set-aside...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis) on January 30, 2026, for transcatheter aortic valve replacement (TAVR) systems. The contract, with an ultimate completion date of March 1, 2026, carries no set-aside designation and represents a sole-source procurement reflecting the contractor's exclusive...
Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on March 20, 2026, with an ultimate completion date of March 23, 2026, reflects the VA's critical need for specialized cardiovascular medical devices to support cardiac surgical programs serving the veteran population. This purchase order carries no set-aside designation and represents a sole-source procurement, consistent with Edwards Lifesciences' exclusive manufacturing capability for advanced transcatheter heart valve technologies including SAPIEN 3 and SAPIEN 3 Ultra valves with RESILIA tissue technology. This award is part of Edwards Lifesciences LLC's extensive ongoing business relationship with the Department of Veterans Affairs, which encompasses over 200 prime federal contract awards since 2025 distributed across multiple Veterans Integrated Service Networks, supplemented by two indefinite delivery vehicles totaling $7.45 million in ceiling value with VISN 21 and VISN 15. The company's VA procurement portfolio primarily consists of firm fixed-price purchase orders ranging from approximately $11,000 to $238,000, with particular concentration in VISN 23, VISN 21, and VISN 17, positioning Edwards Lifesciences as a critical framework supplier of advanced cardiovascular implants and surgical devices essential to veteran healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 3/19/26 |